SERUM ADENOSINE DEAMINASE LEVELS IN ACUTE KIDNEY INJURY
Abstract
Acute kidney injury describes a sudden
decline in kidney function over hours and
days. Acute kidney injury is frequently
caused by renal ischemia and represents
an important cause of morbidity and mortality
of hospitalised patients. Ischemic tissue
damage involves several different
mechanisms including renal inflammation,
direct tubular damage, and alteration of
vascular response. Inflammation leads to
leucocytes infiltration and free radicals release
which result in damage to cell membrane
and the release of membrane associated
enzymes like ADA. ADA is a marker
of the T cell activation and hence important
in acute and protracted inflammatory
response. AIMS AND OBJECTIVES-The
aim of the study is to evaluate the serum
adenosine deaminase activity in patients
with acute kidney injury and to establish a
relationship between ADA activity and
acute kidney injury.MATERIALS AND
METHODS-Study group included 50 individuals
aged 20 to 60 years who were
clinically diagnosed as acute kidney injury
with serum creatinine level greater than
1.5 mgdl and the control group included 50
healthy individuals
ADA activity was measured by the
method of Guisti and Glantis using semiautoanalyser.
RESULTS-The mean ADA
activity in the study group (47.53 plus or
minus 8.81) was significantly high when
compared to the control group (22.06 plus
or minus 5.94) and the P value is statistically
significant. ADA activity was significantly
correlated with Serum creatinine
( P value less than 0.01) and blood urea
( P value less than 0.01).CONCLUSIONThe
present study showed an increased
level of ADA in acute kidney injury. Further
elevated ADA indicates that there is
increase in release of free radicals and an
oxidative damage. There is also increased
metabolism of adenosine and loss of
beneficial effects of adenosine in acute
kidney injury. Hence ADA would be a
novel therapeutic intervention in acute kidney
injury and can be used as a routine
marker of acute kidney injury.
Full Text:
PDFReferences
Clinical chemistry techniques, principle,
correlation, 6th edition, edited
by Michael L. Bishop, Edward
P.fody, Larry E.schoeff , Chapter 26,
Renal function-kara L. Lynch, Alan
H. B.Wie, Page 537 -540, published
by wolters Kluwer/Lippincott Williams
and Wilkins.
Clinical Biochemistry, 2nd edition,
edited by William J. Marshal,
Stephen K bangerk,Chapter 7,The
kidneys, renal function and renal failure-
Suiphin kon and William J marshal,
page 141-143, published by
Elsevier.
Harrison’s principles of internal
medicine, 18th edition , edited by
Longo,Fau c i , K a r p e r , H a u s e r ,
Jameson, Loscalzo ,. 2nd volume
,Chapter 279, Acute kidney Injury-
Shushrut S Waikar, Joseph
V .Bonventre , page 2293-2299,
Published by Mc Graw Hill.
Kumar & clark’s clinical medicine,
edited by parveen kumar & Michael
Clark,
th edition, Chapter11,Renal disease-
MM Yaqoo, page619-624, published by
Elsevier. 5.Tietz text book of clinical
chemistry and molecular diagnostics, 5th
edition ,edited by Carl A brutis,Edward R.
Ashwood,David E .Burns, Chapter 48,
kidney disease-Michael P Delaney,
Christopher .P.Price, Edmund J.
Lamp, page1555-1559, published by Elsevier
Current medical diagnosis and treatment
, 51st edition, edited by
stephen J .Mcpher, Maxine A .papa dakis,.
page-878,Chapter 22, Kidney disease-
Suzanne watnick, Tonja Dirk x,
published by Mc graw hill
Liano F, Junco E, Pascual J, Madero R,
Verde E. The spectrum of acute renal
failure in the intensive care unit compared
with that seen in other settings.
The Madrid Acute Renal Failure Study
Group. Kidney Int Suppl. 1998, 66: S16-
S24. 8Lippincott s illustrated reviews:
Biochemistry. 4th edition . . Nucleotide
metabolism Pamela C. Champe, Richard
A. Harvey et al.. P. 301.published by New
Delhi: Wolters Kluwer /Lippincott Williams
and Wilkins; 2008.
Jae-Geun Lee, Dong Gu Kang et al.,
Changes in Adenosine deaminase activity
in patients with Type 2 Diabetes Mellitus
and effect of DPP-4 Inhibitor treatment on ADA
activity. Diabetes Metabolism J.2011; April: 35
(2):149-158.
C.Uluoglu, B.Cimen, et al., The effect
of experimental diabetes on the circadian
pattern of adenosine deaminase and
myeloperoxidase activities in rat liver.
Gen. Physiol.Biophys. 2008; 27: 25-31
J.P.J. Ungerer, H.M.Oosthuizen et
al., Serum Adenosine deaminase:
Isoenzymes and diagnostic applications.
Clin.Chem.38/7,1322-1326
(1992).
Andrey V.Zavialov and Ake Engstrom.
Human ADA2 belongs to a
new family of growth factors with
Adenosine deaminase activity. Biochem.
J.( 2005); 391:51-57.
Andrey V.Zavialov, Eduard Gracia
et al., Human Adenosine deaminase
induces differentiation of
monocytes into macrophages and
stimulates proliferation of T-Helper
cells and macrophages. Journal of
leucocytes Biology vol.88 no. 2: 279
-290.
Ayse Binnur Erbagci, Rukiye Deveci,
et al., Effect of intensive insulin
therapy on systemic nitric oxide levels
and adenosine deaminase activity
in secondary sulfonylurea failure.
Biochemia Medica 2009; 19 (2):166
-176.
Iraj Khodadadi, Mohammad Abdi
et al., Analysis of serum adenosine
deaminase (ADA) and ADA1 and
ADA2 isoenzyme activities in HIV
positive and HIV-HBV co-infected
patients. Clinical Biochemistry 44
(2011) 980-983.
George P.H.Leung, Ricky
Y.K.Man, et al. D-Glucose upregulates
adenosine transport in cultured
human aortic smooth muscle.
AJP-Heart June 2005 vol.288 no.
H2756 - H2762. 17.saleema umar
V,Nalini k,ravindra prabu, licy
CD,serum ADA
in acute kidney injury,IJCB,Volume
,supplement 2009,P.136-137.
Vallon, muhlbauer, osswald. Adenosine
and kidney function. American
physiological society, July 2006, volume
, no.3, 901-940
Jessica D. Bauerle, Almut Grenz, Jae-
Hwan Kim, H. Thomas Lee,and Holger K.
Eltzschig. Adenosine Generation and
Signaling during Acute Kidney Injury.J
Am Soc Nephrology 22:14-20, 2011
K.C.Vasudha, A.Nirmal kumar et al.,
Studies on the age dependent changes in
serum Adenosinedeaminase activity . Indian
Journal of Clinical Biochemistry.
; 21 (1): 116-120.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr M.G.R. Medical University